본문 바로가기

Data Plus(+)

All 807,818 Page 4,318/80,782

검색

Contents

No Journal_name Subject Date DOI Author
764648 JOURNAL FOR IMMUNOTHERAPY OF CANCER 340 A phase Ib study of the safety and tolerability of pixatimod plus nivolumab in subjects with advanced solid tumors with an expansion cohort in metastatic pancreatic adenocarcinoma (mPDAC) 2021-11-01 10.1136/jitc-2021-sitc2021.340 Lemech Charlotte, Dredge Keith, Bampton Darryn, Hammond Edward, Stanley Amanda, Leveque-ElMouttie Lucie, Chojnowski Grace, Haydon Andrew, Pavlakis Nick, Burge Matthew, Brown Michael, Goldstein David
764647 JOURNAL FOR IMMUNOTHERAPY OF CANCER 339 Immune profiling to investigate improved survival in patients with metastatic triple-negative breast cancer receiving trilaciclib prior to chemotherapy 2021-11-01 10.1136/jitc-2021-sitc2021.339 Stevens Aaron, O’Shaughnessy Joyce, Cao Subing, Sorrentino Jessica, Horton Janet, Yi John, Tan Antoinette
764646 JOURNAL FOR IMMUNOTHERAPY OF CANCER 72 Spatial whole transcriptome profiling of the tumor microenvironment in prostate carcinomas 2021-11-01 10.1136/jitc-2021-sitc2021.072 Anaparthy Naishitha, Giangarra Valeria, Taylor Sarah, Turkekul Mesruh, Williams Stephen, Mielinis Paulius, Gallant Caroline
764645 JOURNAL FOR IMMUNOTHERAPY OF CANCER 869 Locally administered immunotherapy self-delivering RNAi PH-762 results in abscopal clearance of untreated distal tumors, suggesting systemic immune response, in a murine hepatocarcinoma model 2021-11-01 10.1136/jitc-2021-sitc2021.869 Cuiffo Benjamin, Maxwell Melissa, Yan Dingxue, Rivest Brianna, Cardia James, Fricker Simon
764644 JOURNAL FOR IMMUNOTHERAPY OF CANCER 868 Overall survival on tebentafusp in metastatic uveal melanoma (mUM) across the range of tumor gp100 expression levels 2021-11-01 10.1136/jitc-2021-sitc2021.868 Leach Emma, Stanhope Sarah, Naidoo Revashnee, Abdullah Shaad, Collins Laura, Ranade Koustubh
764643 JOURNAL FOR IMMUNOTHERAPY OF CANCER 867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation 2021-11-01 10.1136/jitc-2021-sitc2021.867 Kwant Kathryn, Rocha Sony, Stephenson Katrina, Dayao Maria, Thothathri Subramanian, Banzon Rose, Aaron Wade, Hemmati Golzar, Callihan Evan, Yu Timothy, O’Rear Jessica, Bragg Eric, Kwong Willis, Situ Hubert, Hundal Avneel, Yu Stephen, Jackson Taggra, Wright Kevin, Xiao Yinghua, To Linh, Austin Richard, Lemon Bryan, Wesche Holger, Jack Lin S
764642 JOURNAL FOR IMMUNOTHERAPY OF CANCER 866 RBN-2397, a novel, potent, and selective PARP7 inhibitor, induces tumor-intrinsic type I interferon responses and adaptive immunity in preclinical models and patient tumors 2021-11-01 10.1136/jitc-2021-sitc2021.866 Kuplast-Barr Kristy, Kuplast-Barr Kristy, Johnson Melissa, Patel Manish, Yap Timothy, Falchook Gerald, LoRusso Patricia, Abo Ryan, Liu Chang, Manyak Erika, Cleary Lisa, Bozon Viviana, Parasuraman Sudha, Keilhack Heike, McEachern Kristen
764641 JOURNAL FOR IMMUNOTHERAPY OF CANCER 865 iosH2 exerts potent anti-tumor activity by blocking LILRB1/2 and KIR3DL1 receptor signaling 2021-11-01 10.1136/jitc-2021-sitc2021.865 Belaunzaran Osiris Marroquin, Rafiei Anahita, Kumar Anil, Gualandi Marco, Westphal Magdalena, Vogt Lorenz, Smith Sean, Curran Michael, Renner Christoph
764640 JOURNAL FOR IMMUNOTHERAPY OF CANCER 860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model 2021-11-01 10.1136/jitc-2021-sitc2021.860 Kang Jinho, Joung Eunkyo, Shin Hunwoo, Ahn Byung cheol, Jung Eunjung, Jung Hun, Park Kyong Hwa
764639 JOURNAL FOR IMMUNOTHERAPY OF CANCER 859 Tuning the tumor microenvironment by reprogramming TREM1+ myeloid cells to unleash anti-tumor immunity in solid tumors 2021-11-01 10.1136/jitc-2021-sitc2021.859 Jahchan Nadine, Ramoth Hanna, Juric Vladi, Mayes Erin, Mankikar Shilpa, Mehta Ranna, Binnewies Mikhail, Dash Subhadra, Palmer Rachael, Pollack Joshua, Rudolph Joshua, Canaday Pamela, Haeggblom Linnea, Santamaria Carlos, Du xiaoyan, Reyno Leonard, Baker Kevin, Liang Linda